会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Yeast mutants useful for indentifying immunosupressants
    • 酵母突变体可用于鉴定免疫抑制剂
    • US5324659A
    • 1994-06-28
    • US923082
    • 1992-07-31
    • Stephen A. ParentLeonardo E. BrizuelaGary L. ChrebetKeith A. Bostian
    • Stephen A. ParentLeonardo E. BrizuelaGary L. ChrebetKeith A. Bostian
    • C12N1/16C12N15/01C12Q1/02C12R1/865G01N33/50
    • C12R1/85C12N15/01G01N33/5008Y10S435/942
    • Disclosed is a process utilizing yeast mutants for identifying active FK-506 type immunosuppressants. The process utilizes Saccharomyces cerevisiae mutants containing an fkr1, fkr2, fkr3 mutant gene or mixture thereof, which are resistant to FK-506 but sensitive to rapamycin. These mutants can be used in a diagnostic procedure for identifying FK-506 and FK-506 type immunosuppressants and in screening assays for compounds and fermentation broths which exhibit FK-506 type immunosuppressive activity. Specifically disclosed are the new yeast mutants, Saccharomyces cerevisiae YKF093, (Merck Culture Collection No. MY 2088) ATCC No. 74055, containing an fkr3 mutant gene, Saccharomyces cerevisiae YKF 012, (Merck Culture Collection No. MY 2096) ATCC No. 74061, which contains an fkr1 mutant gene, Saccharomyces cerevisiae YFK 014, (Merck Culture Collection No. MY 2097) ATCC No. 74062 and YFK-023-17A (Merck Culture Collection No. MY 2098) ATCC No. 74063, both which contain an fkr2 mutant gene and are useful in identifying active FK-506 type immunosuppressants.
    • 公开了利用酵母突变体鉴定活性FK-506型免疫抑制剂的方法。 该方法利用含有fKr1,fkr2,fkr3突变基因或其混合物的酿酒酵母突变体,其对FK-506具有抗性,但对雷帕霉素敏感。 这些突变体可用于鉴定FK-506和FK-506型免疫抑制剂的诊断程序,并用于展示FK-506型免疫抑制活性的化合物和发酵肉汤的筛选试验。 具体公开的是含有fkr3突变基因,酿酒酵母YKF 012(Merck Culture Collection No. MY 2096)ATCC No.74061的新酵母突变体,酿酒酵母YKF093(Merck Culture Collection No. MY 2088)ATCC No.74055 ,其含有fkr1突变基因,酿酒酵母YFK 014(Merck Culture Collection No. MY 2097)ATCC No.74062和YFK-023-17A(Merck Culture Collection No. MY 2098)ATCC No.74063,它们都含有 fkr2突变基因,可用于鉴定活性FK-506型免疫抑制剂。
    • 3. 发明授权
    • Replica plating device
    • 复制电镀装置
    • US5587322A
    • 1996-12-24
    • US344217
    • 1994-11-23
    • Gary L. Chrebet
    • Gary L. Chrebet
    • C12M1/26C12M1/32
    • C12M33/14C12M23/04C12M23/20
    • A device for replica plating of cellular colonies. The device has a solid body with a first region and a first end coupled to a peripheral ridge. A ridge is disposed at the transition from the first region to the peripheral ridge. A sheet of material capable of transferring cellular colonies from one medium to another is placed over the first end and the first region. A locking element defining an aperture passes over the first region and the sheet of material creating a frictional fit which pulls the sheet of material taut over the first end. The sheet of material is compressed between the locking element and the peripheral ridge thereby holding the sheet of material in place.
    • 用于细胞集落复制电镀的装置。 该装置具有固体,其具有第一区域,第一端部联接到外围脊部。 在从第一区域到外围脊的过渡处设置脊。 能够将细胞集落从一种培养基转移到另一种培养基的材料片放置在第一端和第一区上。 限定孔径的锁定元件穿过第一区域,并且该材料片材产生摩擦配合,其将片材拉伸在第一端部上。 该片材料在锁定元件和周边脊之间被压缩,从而将材料片保持在适当位置。